Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × darolutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 28 Prostatic Neoplasms, Castration-Resistant 3 Urogenital Neoplasms 2 Prostatic Diseases 2 Neoplasms 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 Metastatic Castration-resistant Prostate Cancer 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Salivary Gland Neoplasms 1 Prostate Adenocarcinoma 1 Non-metastatic Castration-resistant Prostate Cancer 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Neoplasms 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumor 1

Interventions

ruxolitinib 11 fludarabine 5 Tacrolimus 5 Stem Cell Transplantation 5 Specimen Handling 5 Cyclophosphamide 5 Whole-Body Irradiation 4 fludarabine phosphate 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 selinexor 2 navitoclax 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Decitabine 2 Blood Component Removal 2 Biopsy 2 Azacitidine 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 veliparib 1 piperine 1 pevonedistat 1 pegylated granulocyte colony-stimulating factor 1 merphos 1 letermovir 1 iadademstat 1 fedratinib 1 demethoxycurcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡